Market Overview:

The Point of Care Diagnostics Market size is estimated to reach $25 Billion by 2031, growing at a CAGR of 9.7% during the forecast period 2025-2031, according to a recent report published by IndustryARC, titled, “Point of Care Diagnostics Market – By Sample Type (Blood, Urine, Saliva, Nasal, Throat & Buccal Swabs, Others), By Product (Devices, Reagents & Consumables, Software & Services), By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Biosensors, Others), By Application (Infectious Disease Testing, Cardiac Markers, Diabetes Monitoring, Pregnancy Tests, Drug Abuse Testing, Lipid Panel Testing, Urinalysis, Others), By Mode of Testing (Prescription-based POC Testing, Over-the-Counter (OTC) POC Testing), By End User (Hospitals and Clinics, Home Care, Diagnostic Laboratories, Others), By Distribution Channel (Pharmacies & Drugstores, Online Pharmacies, Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2025-2031”

People need better diagnostic tools because more people get chronic and infectious diseases. The need for healthcare services anywhere has made point-of-care testing more popular. New technology improves how POC testing devices work and performs their functions better. The lower costs and shorter results times make these testing systems very appealing for speedy diagnostic use. The growing number of elderly people drives the market because they need fast and easy healthcare options.

North America Dominated the Market in 2024:

North America is leading the Point of Care (POC) diagnostics market due to the high prevalence of chronic diseases, like diabetes and the crucial demand for rapid diagnostic solutions. In Fiscal Year (FY) 2025, the U.S. Department of Health and Human Services (HHS) suggested allocating $130.7 billion in discretionary and $1.7 trillion in mandated funding for healthcare. North America is the largest market for POC diagnostics due to the advanced healthcare infrastructure, high investment in healthcare and rising chronic disease burden. The region also benefits from strong regulatory support, continuous technological advancements, and growing adoption of at-home diagnostic solutions, further driving market expansion.

Point of Care Diagnostics Market: Key Takeaways

Growing Demand for Decentralized Healthcare Solutions:

The Point of Care Diagnostics Market is driven by the rising demand for decentralized healthcare solutions. In September 2024, C2N Diagnostics secured $7.025 million from the Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator to develop a decentralized mass spectrometry platform for Alzheimer’s testing. This funding supports scalable, high-performance diagnostics in clinical labs, reducing reliance on centralized systems. The shift toward decentralized healthcare enables timely, cost-effective, and accessible testing. As the need for remote and at-home diagnostics grows, advancements in technology and evolving healthcare dynamics are accelerating POC market expansion, ensuring broader access to critical health insights and improved patient outcomes. 

For More Queries About "Point of Care Diagnostics Market " @ https://www.industryarc.com/pdfdownload.php?id=501284

Technological Advancements:

Technological advancements drive the Point of Care Diagnostics Market growth by producing fast accurate and effective diagnostic tools. During June 2024 the PA-100 AST System from Sysmex Astrego received a £10 million Longitude Prize award for its life-changing UTI diagnostic technology. The system provides quick reliable results that help doctors select proper antibiotics to fight antibiotic resistance worldwide. In September 2024 at the 29th ADLM International Critical & Point of Care Testing Symposium Perosphere Technologies displayed ClotChek to demonstrate how new POC technology solves important healthcare problems. ClotChek produces accurate WBCT results in just 3 to 8 minutes by testing a single drop of blood. New technologies in point-of-care testing help doctors make better medical decisions faster and provide more accurate results for patients in both emergency and regular settings. 

Scope of the Report: 

Report Metric

Details

Base Year Considered

2024

Forecast Period

2025–2031

CAGR

9.7%

Market Size in 2031

$25 Billion


Segments Covered

By Sample Type, By Product, By Platform, By Application, By Mode of Testing, By End User, By Distribution Channel and By Geography.





Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Netherlands, Denmark, Belgium and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Thailand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).





Key Market Players

1.      Abbott Laboratories

2.      Siemens Healthineers AG

3.      F. Hoffmann-La Roche Ltd.

4.      Danaher Corporation

5.      Becton, Dickinson and Company

6.      QuidelOrtho Corporation

7.      Thermo Fisher Scientific Inc.

8.      bioMérieux SA

9.      EKF Diagnostics Holdings plc

10.  Trinity biotech plc



Recent Developments:

• In July 2024, Roche completed the acquisition of LumiraDx’s Point of Care technology after receiving all necessary antitrust and regulatory approvals. The move strengthens Roche’s diagnostics portfolio, enabling expansion into decentralized patient care and enhancing global access to diagnostic testing in primary care through LumiraDx's innovative multi-assay platform.

• In April 2024, F. Hoffmann-La Roche Ltd. India launched its point-of-care NT-proBNP test for diabetics at risk of heart failure. Available on the cobas h 232 system, the test enables faster diagnosis and early risk identification, addressing the high cardiovascular disease burden among type 2 diabetics and improving disease management through timely interventions. 

Point of Care Diagnostics Market: Competitive Landscape

Key companies profiled in the Point of Care Diagnostics Market are Abbott Laboratories, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Danaher Corporation, Becton, Dickinson and Company, QuidelOrtho Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, EKF Diagnostics Holdings plc, Trinity biotech plc and others.

Related Reports:

Point of Care Diagnostic Devices Market - Point of Care Diagnostic Devices Market Size is forecast to reach $ 58570.9 Million by 2030, at a CAGR of 6.20% during forecast period 2025-2031. Market growth is primarily driven by the increasing demand for rapid diagnostic results and the growing prevalence of chronic diseases, especially diabetes and cardiovascular conditions.

Full-Sized Point of Care CT Imaging Market - Full-Sized Point Of Care CT Imaging Market size is estimated to reach $1.1 billion by 2027, growing at a CAGR of 12.5% during the forecast period 2022-2027. Owing to the rising global incidence of diabetes and the advancements in minimally invasive technologies for blood sugar monitoring.

Needle Free Injection Systems Market - Point of Care Infectious Disease Market size was estimated at $1.9 billion in 2020, projected to grow at a CAGR of 12.3% during the forecast period 2021-2026. The market growth is fueled by the increasing demand for painless and efficient drug delivery systems and the rising prevalence of infectious diseases globally.

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.  
IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.

Contact Us:
Mr. Venkat Reddy
IndustryARC
USA: (+1) 518-282-4727